Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Recurrence and CYP2B6[original query] |
---|
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast cancer research : BCR 2010 12 (3): R26. Gor Priya P, Su H Irene, Gray Robert J, Gimotty Phyllis A, Horn Michelle, Aplenc Richard, Vaughan William P, Tallman Martin S, Rebbeck Timothy R, DeMichele Ange |
Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer. Cancer chemotherapy and pharmacology 2015 Jan 75 (1): 207-14. Haroun F, Al-Shaar L, Habib R H, El-Saghir N, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, Cascorbi I, Zgheib N |
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma. European journal of cancer (Oxford, England : 1990) 2016 Jan 55 56-64. Veal Gareth J, Cole Michael, Chinnaswamy Girish, Sludden Julieann, Jamieson David, Errington Julie, Malik Ghada, Hill Christopher R, Chamberlain Thomas, Boddy Alan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: